TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo
Cells · 2023
DOI: 10.3390/cells12121597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Audrey Lee-Gosselin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Tauopathies. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, Precision Health Initiative in Alzheimer’s Disease at Indiana University School of Medicine.
Abstract (Originalsprache)
The role of TREM2 in Alzheimer’s disease (AD) is not fully understood. Previous studies investigating the effect of TREM2 deletion on tauopathy mouse models without the contribution of b-amyloid have focused only on tau overexpression models. Herein, we investigated the effects of TREM2 deficiency on tau spreading using a mouse model in which endogenous tau is seeded to produce AD-like tau features. We found that Trem2−/− mice exhibit attenuated tau pathology in multiple brain regions concomitant with a decreased microglial density. The neuroinflammatory profile in TREM2-deficient mice did not induce an activated inflammatory response to tau pathology. These findings suggest that reduced TREM2 signaling may alter the response of microglia to pathological tau aggregates, impairing their activation and decreasing their capacity to contribute to tau spreading. However, caution should be exercised when targeting TREM2 as a therapeutic entry point for AD until its involvement in tau aggregation and propagation is better understood.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Department of Radiology & Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA.
- Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN 47907, USA.
ORCID-Profile: Luke Dabin, Jean-Christophe Rochet, Jungsu Kim, Cristian A Lasagna-Reeves
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- Precision Health Initiative in Alzheimer’s Disease at Indiana University School of Medicine
- NIH/NIA
- NIH/NINDS
- Department of Defense award
- NSF CBET
Zitieren
APA
Lee-Gosselin, A., Jury-Garfe, N., You, Y., Dabin, L., Soni, D., Dutta, S., Rochet, J. C., Kim, J., Oblak, A. L., & Lasagna-Reeves, C. A. (2023). TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo. Cells. https://doi.org/10.3390/cells12121597
Vancouver
Lee-Gosselin A, Jury-Garfe N, You Y, Dabin L, Soni D, Dutta S, et al. TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo. Cells. 2023. doi:10.3390/cells12121597
BibTeX
@article{LeeGosselin2023,
author = {Lee-Gosselin, Audrey and Jury-Garfe, Nur and You, Yanwen and Dabin, Luke and Soni, Disha and Dutta, Sayan and Rochet, Jean-Christophe and Kim, Jungsu and Oblak, Adrian L and Lasagna-Reeves, Cristian A},
title = {TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12121597}
}
EUVIMED